Weekly docetaxel monotherapy for advanced gastric or esophagogastric junction cancer

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation

Mary E. Charlson, Peter Pompei, Kathy L. Aleš et al. · Journal of Chronic Diseases · 1987 · 49.9K citations

Public Health, Biostatistics, Clinical Classification Systems +15

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

Medicine, Oncology, Cancer Pharmacology +12

Participation in Cancer Clinical Trials

Vivek H. Murthy, Harlan M. Krumholz, Cary P. Gross · JAMA · 2004 · 2.1K citations

Medicine, Oncology, Cancer Epidemiology +16

Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group

Eric Van Cutsem, Vladimir Moiseyenko, Sergei Tjulandin et al. · Journal of Clinical Oncology · 2006 · 1.9K citations · Full text

Medicine, Oncology, Pharmacology +11

Classification of adenocarcinoma of the oesophagogastric junction

J. R. Siewert, H. J. Stein · British journal of surgery · 1998 · 1.3K citations

Medicine, Oncology, Surgery +12